Davis Andrew S.'s Form 4 filing
Silk Road Medical Inc (SILK) · filed Nov 2, 2021
- Accession no.
- 0001593968-21-002347
- Filed
- Nov 2, 2021
- Trade date
- Nov 1, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 10 non-derivative transactions and 5 derivative transactions. Open-market sales total $292.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davis Andrew S.CIK 0001770191 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2021 | Common Stock | MOption exerciseAcquired | +121 | $6.11 | +$739.31 | 70,376 | Direct | |
| Nov 1, 2021 | Common Stock | SSaleDisposed | −121 | $60.96F2 | −$7,376.16 | 70,255 | Direct | |
| Nov 1, 2021 | Common Stock | MOption exerciseAcquired | +3,343 | $20.00 | +$66,860 | 73,598 | Direct | |
| Nov 1, 2021 | Common Stock | SSaleDisposed | −3,343 | $60.96F2 | −$203,789.28 | 70,255 | Direct | |
| Nov 1, 2021 | Common Stock | MOption exerciseAcquired | +988 | $30.93 | +$30,558.84 | 71,243 | Direct | |
| Nov 1, 2021 | Common Stock | SSaleDisposed | −988 | $60.96F2 | −$60,228.48 | 70,255 | Direct | |
| Nov 1, 2021 | Common Stock | MOption exerciseAcquired | +321 | $4.73 | +$1,518.33 | 70,576 | Direct | |
| Nov 1, 2021 | Common Stock | SSaleDisposed | −321 | $60.96F2 | −$19,568.16 | 70,255 | Direct | |
| Nov 1, 2021 | Common Stock | MOption exerciseAcquired | +32 | $52.07 | +$1,666.24 | 70,287 | Direct | |
| Nov 1, 2021 | Common Stock | SSaleDisposed | −32 | $60.96F2 | −$1,950.72 | 70,255 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2021 | Common Stock | MOption exerciseDisposed | −121 | $0.00 | $0 | 2,647 | Direct | |
| Nov 1, 2021 | Common Stock | MOption exerciseDisposed | −3,343 | $0.00 | $0 | 33,694 | Direct | |
| Nov 1, 2021 | Common Stock | MOption exerciseDisposed | −988 | $0.00 | $0 | 31,187 | Direct | |
| Nov 1, 2021 | Common Stock | MOption exerciseDisposed | −321 | $0.00 | $0 | 27,084 | Direct | |
| Nov 1, 2021 | Common Stock | MOption exerciseDisposed | −32 | $0.00 | $0 | 6,068 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at price ranging from $60.74 to $61.31. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 5 transactions in Table I.